Our annual ranking returns ...
The issues are piling on for the healthcare leader, but this one is nowhere near insurmountable.
Indian health-tech startup Healthify is in talks to partner with more weight-loss drugmakers to offer health, nutrition and ...
Former Novo Nordisk CSO Marcus Schindler on R&D leadership, pharma innovation, scientific discovery, AI, global talent, DEI, biotech, drug development strategy.
MedPage Today on MSN
Large study links diabetes to higher risk of sudden cardiac death
Increased risk "most striking" in younger adults, researchers say ...
Novo Nordisk's weight on GDP, jobs, and exports is reshaping Denmark's growth story despite layoffs and tariff headwinds.
GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...
Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...
Denmark on Thursday sharply raised its economic growth forecast for 2025, due in part to the pharmaceuticals industry, which ...
An Indian court has allowed Dr. Reddy’s Laboratories Ltd. to manufacture and export generic versions of Novo Nordisk A/S’s ...
Denmark raised its growth projections for this year and the next, suggesting Novo Nordisk A/S is able to fuel the Nordic ...
Gynaecological disorders such as endometriosis, PCOS, and menstrual irregularities are common and often associated with pain and disruption to everyday life. They are typically diagnosed late, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results